HYPOTHERMIA AND TRAUMATIC BRAIN INJURY

体温过低和创伤性脑损伤

基本信息

项目摘要

In this feasibility proposal we are seeking support for the development of a comprehensive clinical and basic science head-injury research center. We will study the therapeutic value and potential mechanisms of action of moderate hypothermia administered after head injury. Data from our laboratories suggest that mild to moderate cerebral hypothermia used after global cerebral ischemia in dogs improves outcome and reduces mortality. Recent studies in a rodent fluid percussion model also suggest that hypothermia improves outcome, and that hypothermia may be more effective than many other types of therapy. In our clinical projects we will randomize adult victims of severe closed-head-injury to a normothermia group or a group cooled to 32-33 degree centigrade for 24 hours after their injury. Emphasis will be placed on cooling as soon as possible following the injury. Physiologic, metabolic and blood flow measurements will be made at frequent intervals during the first five days after injury, and the influence of hypothermia on these parameters will be assessed through statistical comparison of values from the experimental and control groups. Clinical outcome in both groups will also be carefully assessed and recorded. In our basic science projects we will define potential mechanisms through which hypothermia may be effective, determine the time interval following injury during which hypothermia might be expected to be effective, and determine if the use of high-dose steroids might enhance the efficacy of moderate hypothermia. These projects will complement the clinical projects by systematically analyzing ventricular cerebrospinal fluid (CSF) and brain tissue specimens obtained from human head-injured subjects for interleukin-1, glutamate and aspartate to define their role as mediators of secondary brain injury, and the effect of hypothermia on their concentration in CSF and brain tissue. In a rodent focal cerebral contusion model we will use microdialysis to investigate the time course of appearance of these neurochemicals in the extracellular space, and the effect of hypothermia on suppression of their production. In this same experimental paradigm we also will investigate the effects of hypothermia on nerve growth factor concentrations, and density and function of NMDA receptors. Using behavioral and histological analysis we will define the time interval after blunt head injury in rats and epidural compression injury in dogs during which hypothermia might still be efficacious. Finally, we will determine if a combination of high-dose steroids and moderate hypothermia will prolong the therapeutic window during which treatment can be administered. The projects submitted in this head-injury center proposal are designed to answer fundamental questions about the mechanisms of action of hypothermia in head injury, and its effect on cerebral physiology, metabolism and blood flow. Our results will provide the groundwork for a multicenter clinical trial of moderate hypothermia.
在此可行性建议中,我们正在寻求支持的发展 全面的临床和基础科学负责人研究中心。 我们 将研究的治疗价值和潜在的作用机理 头部受伤后施用中等温度。 来自我们的数据 实验室表明,在 狗的全球脑缺血改善了预后并降低死亡率。 在啮齿动物打击乐模型中的最新研究也表明 体温过低会改善预后,而体温过低可能更有效 比许多其他类型的疗法。 在我们的临床项目中,我们将 将严重闭合伤害的成年受害者随机与正常炎 小组或一组冷却至32-33度摄氏度,持续24小时 受伤。 重点将尽快放置冷却 受伤。 生理,代谢和血流测量将是 在受伤后的前五天,以频繁的间隔制作 体温过低对这些参数的影响将通过 实验组和对照组的值的统计比较。 两组的临床结果也将仔细评估,并且 记录。 在我们的基础科学项目中,我们将定义潜力 低温可能有效的机制,确定时间 受伤后的间隔可能预期体温过低 有效,并确定使用高剂量类固醇是否会增强 中度低温的功效。 这些项目将补充 临床项目通过系统地分析心室脑脊 流体(CSF)和脑组织标本从人头受伤的 白介素-1,谷氨酸和天冬氨酸的受试者将其作用定义为 继发性脑损伤的介体,以及体温过低的影响 CSF和脑组织的浓度。 在啮齿动物局部脑大脑中 挫伤模型我们将使用微透析研究时间过程 这些神经化学物质在细胞外空间中的外观, 体温过低对抑制其生产的影响。 同样 实验范式我们还将研究体温过低的影响 在神经生长因子浓度以及NMDA的密度和功能上 受体。 使用行为和组织学分析,我们将定义 大鼠钝性头部受伤和硬膜外压缩后的时间间隔 低温可能仍有效的狗受伤。 最后,我们将确定高剂量类固醇和 中度的体温过低将延长治疗窗口 可以进行治疗。 在此遭受损害中提交的项目 中心建议旨在回答有关 体温过低在头部受伤中的作用机制及其对 脑生理,代谢和血流。 我们的结果将提供 中等体温过低的多中心临床试验的基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Donald W. Marion其他文献

Effect of neuromuscular blockers and opiates on the cerebrovascular response to endotracheal suctioning in adults with severe head injuries.
神经肌肉阻滞剂和阿片类药物对严重头部损伤成人气管内抽吸脑血管反​​应的影响。
  • DOI:
  • 发表时间:
    1998
  • 期刊:
  • 影响因子:
    2.7
  • 作者:
    M. M. Kerr;Susan M. Sereika;Patricia A. Orndoff;B. Weber;Ellen B. Rudy;Donald W. Marion;Kathleen S. Stone;Barbara S. Turner
  • 通讯作者:
    Barbara S. Turner

Donald W. Marion的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Donald W. Marion', 18)}}的其他基金

CORE--CLINICAL FACILITY
核心——临床设施
  • 批准号:
    6565231
  • 财政年份:
    2002
  • 资助金额:
    $ 32.95万
  • 项目类别:
CORE--BIOSTATISTICS
核心--生物统计学
  • 批准号:
    6565230
  • 财政年份:
    2002
  • 资助金额:
    $ 32.95万
  • 项目类别:
CORE--BIOSTATISTICS
核心--生物统计学
  • 批准号:
    6445544
  • 财政年份:
    2001
  • 资助金额:
    $ 32.95万
  • 项目类别:
CORE--BIOSTATISTICS
核心--生物统计学
  • 批准号:
    6448236
  • 财政年份:
    2001
  • 资助金额:
    $ 32.95万
  • 项目类别:
CORE--CLINICAL FACILITY
核心——临床设施
  • 批准号:
    6448237
  • 财政年份:
    2001
  • 资助金额:
    $ 32.95万
  • 项目类别:
fMRI and Sports-Related Concussion
fMRI 和运动相关脑震荡
  • 批准号:
    6422928
  • 财政年份:
    2001
  • 资助金额:
    $ 32.95万
  • 项目类别:
CORE--CLINICAL FACILITY
核心——临床设施
  • 批准号:
    6445545
  • 财政年份:
    2001
  • 资助金额:
    $ 32.95万
  • 项目类别:
CORE--CLINICAL FACILITY
核心——临床设施
  • 批准号:
    6314147
  • 财政年份:
    2000
  • 资助金额:
    $ 32.95万
  • 项目类别:
CORE--BIOSTATISTICS
核心--生物统计学
  • 批准号:
    6314146
  • 财政年份:
    2000
  • 资助金额:
    $ 32.95万
  • 项目类别:
CORE--CRITICAL CARE
核心——重症监护
  • 批准号:
    6112404
  • 财政年份:
    1999
  • 资助金额:
    $ 32.95万
  • 项目类别:

相似海外基金

Dissemination and implementation of DIGEST™ as an evidence-based measurement tool for dysphagia in cancer
传播和实施 DIGEST™ 作为癌症吞咽困难的循证测量工具
  • 批准号:
    10584824
  • 财政年份:
    2023
  • 资助金额:
    $ 32.95万
  • 项目类别:
Rusalatide Acetate (TP508) Mitigation Effect on Radiation Induced Keratopathy
醋酸鲁沙来肽 (TP508) 对放射诱发的角膜病变的缓解作用
  • 批准号:
    10605739
  • 财政年份:
    2023
  • 资助金额:
    $ 32.95万
  • 项目类别:
Vestibular and neck muscle contributions to head control in response to induced head perturbations and falls in balance-impaired older adults
前庭和颈部肌肉对头部控制的贡献,以应对平衡受损老年人的头部扰动和跌倒
  • 批准号:
    10789703
  • 财政年份:
    2023
  • 资助金额:
    $ 32.95万
  • 项目类别:
Spatialomics and quantitative MRI of ischemic injury in a piglet model of Legg-Calve-Perthes disease
Legg-Calve-Perthes 病仔猪模型缺血性损伤的空间组学和定量 MRI
  • 批准号:
    10806492
  • 财政年份:
    2023
  • 资助金额:
    $ 32.95万
  • 项目类别:
Determining the ultrastructural differences between dually and singly innervated dendritic spines and their changes following glutamate excitotoxicity using Cryo-Electron Tomography
使用冷冻电子断层扫描确定双重和单神经支配的树突棘之间的超微结构差异及其在谷氨酸兴奋性毒性后的变化
  • 批准号:
    10679214
  • 财政年份:
    2023
  • 资助金额:
    $ 32.95万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了